Unit Converter
17-Hydroxyprogesterone

SI UNITS (recommended)

CONVENTIONAL UNITS

Synonyms:

  • 17-OHP
  • 17-OH Progesterone
  • 17α-Hydroxyprogesterone (17α-OHP)
  • Hydroxyprogesterone (OHP)
  • 17 Alphahydroxyprogesterone
  • 17α-hydroxypregn-4-ene-3,20-dio

Units of Measurement:

  • nmol/L
  • ng/mL
  • ng/dL
  • ng/100mL
  • ng%
  • ng/L
  • µg/L

Synonyms

  • 17-OHP
  • 17-Hydroxyprogesterone
  • 17-α-Hydroxyprogesterone
  • 17-OH-Progesterone
  • OHPG (older abbreviation)

Units of Measurement

ng/dL, ng/mL, µg/L, nmol/L, pmol/L
(Varies by assay and country)

Description

17-Hydroxyprogesterone (17-OHP) is a steroid hormone produced in the adrenal cortex and gonads. It is a key intermediate in the synthesis of:

  • Cortisol
  • Androgens
  • Progesterone pathway hormones

It becomes clinically relevant because elevated levels indicate impaired cortisol synthesis, most commonly in 21-Hydroxylase Deficiency (21-OHD) — the leading cause of Congenital Adrenal Hyperplasia (CAH).

Physiological Role

1) Intermediate in Steroidogenesis

Pathway:

Cholesterol → Pregnenolone → 17-OHP → 11-Deoxycortisol → Cortisol

2) Adrenal & Gonadal Secretion

Adrenal cortex (zona fasciculata + zona reticularis) is the major producer.
Gonads contribute mildly, especially in luteal phase.

3) ACTH-Dependent Regulation

High ACTH → high 17-OHP
Low ACTH → low 17-OHP

Hence, CAH patients show very high 17-OHP due to compensatory ACTH stimulation.


Clinical Significance

A) Elevated 17-OHP

Most important causes:

  • Congenital Adrenal Hyperplasia (CAH)
    • Classic (salt-wasting or simple virilizing)
    • Non-classic CAH (late-onset)
  • Adrenal tumors
  • PCOS (mild elevation)
  • Preterm infants (physiological elevation)

B) Low 17-OHP

  • Steroidogenic defects upstream
  • Adrenal insufficiency
  • Exogenous glucocorticoid therapy

Reference Intervals (Tietz 8E + ESAP 2024 + Mayo Verified)

GroupReference Range
Adults – Male< 220 ng/dL (SI: < 6.67 nmol/L)
Female – Follicular< 80 ng/dL (SI: < 2.42 nmol/L)
Female – Luteal< 285 ng/dL (SI: < 8.64 nmol/L)
Female – Postmenopausal< 51 ng/dL (SI: < 1.55 nmol/L)
Newborn (first 24–72 h)100–1000 ng/dL* (varies widely; crucial for CAH screening)
Preterm infantsSignificantly higher (immature adrenal cortex)

*Newborn ranges vary by birth weight and day of sampling — interpret with caution.
(Tietz 8E + ESAP 2024 endocrine table confirms these ranges.)


17-OHP in Newborn Screening

Why newborn values are high?

Adrenal immaturity + stress of delivery → physiologic elevation.

Hence:

  • Term infant: lower baseline
  • Preterm infant: higher values → higher false positives
  • Low-birth-weight infants: require corrected ranges

Modern screening uses:

  • Fluoroimmunoassay (first-tier)
  • LC–MS/MS (second-tier) for accuracy

Clinical Use Cases

1) Diagnosis of CAH (21-Hydroxylase Deficiency)

Basal levels:

  • > 2,000 ng/dL → classic CAH
  • 200–800 ng/dL → possible non-classic CAH → ACTH stimulation test needed
  • < 200 ng/dL → usually normal

2) ACTH Stimulation Test

After cosyntropin (250 µg) injection:

  • Peak > 1,000 ng/dL strongly suggests CAH
  • Used particularly in:
    • Ambiguous genitalia
    • Hirsutism
    • PCOS vs non-classic CAH
    • Adrenal tumors

3) Monitoring CAH therapy

Glucocorticoids suppress 17-OHP levels.
Targets vary by center but typically:

  • Avoid very high peaks (undertreatment)
  • Avoid very low values (overtreatment, Cushingoid risks)

Units Description & Conversions

Unit Meanings

UnitMeaning
ng/dLnanogram per deciliter
ng/mLnanogram per milliliter
µg/Lmicrogram per liter
nmol/Lnanomole per liter

Conversions

Molecular weight of 17-OHP ≈ 330.45 g/mol

  • ng/dL → nmol/L:

nmol/L=ng/dL×0.0303\text{nmol/L} = \text{ng/dL} \times 0.0303nmol/L=ng/dL×0.0303

  • nmol/L → ng/dL:

ng/dL=nmol/L×33\text{ng/dL} = \text{nmol/L} \times 33ng/dL=nmol/L×33

  • ng/mL → nmol/L:

nmol/L=ng/mL×3.03\text{nmol/L} = \text{ng/mL} \times 3.03nmol/L=ng/mL×3.03


Clinical Pearls

  • Early-morning sampling is ideal due to ACTH circadian rhythm.
  • Luteal phase 17-OHP is naturally higher — avoid misclassification.
  • Preterm infants can show extremely high 17-OHP without CAH.
  • In PCOS, levels are mildly elevated; CAH shows distinctly higher values.
  • LC–MS/MS is preferred for exact measurement — minimizes false positives.

Interesting Medical Fact

17-OHP became a universal newborn screening marker after the 1977 discovery that CAH caused dangerously low cortisol and salt-wasting crises in newborns — early detection has since saved thousands of lives.


SEO-Friendly Converter Text

17-Hydroxyprogesterone (17-OHP) unit conversion calculator. Convert 17-OHP levels between ng/dL, ng/mL, µg/L, and nmol/L using molecular-weight–accurate formulas. Includes pediatric and adult reference intervals, CAH diagnostic cutoffs, and endocrine interpretation.


References (Verified)

Primary

  1. Tietz Clinical Chemistry and Molecular Diagnostics, 8th Edition — Steroid hormones section.
  2. ESAP 2024 — Endocrine reference intervals (17-OHP table).

Secondary

  1. Mayo Clinic Laboratories — 17-OHP pediatric & adult reference ranges.
  2. ARUP Consult — Congenital Adrenal Hyperplasia testing.
  3. NIH / NLM — Steroidogenesis pathways.
  4. Turcu AF et al. “Nonclassic CAH: Diagnosis and Management.” Endocr Rev.
  5. Speiser PW. “Congenital adrenal hyperplasia.” N Engl J Med.

Last updated: December 5, 2025

Reviewed by : Medical Review Board

Other Convertors